Amyotrophic lateral sclerosis (ALS) appears to result from a number of abnormal physiological processes occurring simultaneously. In order to address all the known pathophysiologies of ALS, multiple drugs used would have to include: a glutamate antagonist, an antioxidant, a centrally acting anti-inflammatory agent, a microglial cell modulator, an anti-apoptotic agent, a neurotrophic growth factor, and […]
